Hpv Type 11 L1 Protein

ATC — · 2 markets · 6 records

Hpv Type 11 L1 Protein 2 markets · 6 records Forms

AU 5 records · 2 strengths

  • 0.04 mginjectionGARDASIL 9 Human Papillomavirus 9-valent Vaccine, Recombinant, 30, 40, 60, 40, 20, 20, 20, 20, 20 micrograms / 0.5mL, suspension for injection, vialGARDASIL 9 Human Papillomavirus 9-valent Vaccine, Recombinant, 30, 40, 60, 40, 20, 20, 20, 20, 20 micrograms/0.5mL, suspension for injection, syringe、GARDASIL HPV 6 L1 Protein / HPV 11 L1 Protein / HPV 16 L1 Protein / HPV 18 L1 Protein 20,40,40,20 micrograms/0.5mL sterile liquid syringe、GARDASIL HPV 6 L1 Protein / HPV 11 L1 Protein / HPV 16 L1 Protein / HPV 18 L1 Protein 20,40,40,20 micrograms/0.5mL sterile liquid vial unknown

Records without a stated strength · 1 GARDASIL 9

TW 1 records · 1 strengths

    Records without a stated strength · 1 Gardasil 9 [Human Papillomavirus 9-valent Vaccine, Recombinant]、嘉喜 [九價人類乳突病毒(第6, 11, 16, 18, 31, 33, 45, 52, 58型)基因重組疫苗]

    The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

    Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

    A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.